|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001898,
umls-concept:C0003006,
umls-concept:C0003009,
umls-concept:C0033268,
umls-concept:C0033382,
umls-concept:C0042397,
umls-concept:C0042449,
umls-concept:C0086418,
umls-concept:C0230372,
umls-concept:C1280500,
umls-concept:C1328650,
umls-concept:C1515655,
umls-concept:C1710236
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2001-10-9
|
|
pubmed:abstractText |
[Pro(11)(D)-Ala(12)] angiotensin I is an ACE-resistant substrate specific for chymase. We used this peptide to determine whether a functionally significant non-ACE angiotensin (Ang) II-generating pathway exists in human dorsal hand veins.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin I,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Chymases,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/angiotensin I, Pro(11)-Ala(12)-,
http://linkedlifedata.com/resource/pubmed/chemical/irbesartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1805-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11591618-Administration, Oral,
pubmed-meshheading:11591618-Angina Pectoris,
pubmed-meshheading:11591618-Angiotensin I,
pubmed-meshheading:11591618-Angiotensin II,
pubmed-meshheading:11591618-Angiotensin Receptor Antagonists,
pubmed-meshheading:11591618-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:11591618-Antihypertensive Agents,
pubmed-meshheading:11591618-Biphenyl Compounds,
pubmed-meshheading:11591618-Captopril,
pubmed-meshheading:11591618-Chronic Disease,
pubmed-meshheading:11591618-Chymases,
pubmed-meshheading:11591618-Dose-Response Relationship, Drug,
pubmed-meshheading:11591618-Double-Blind Method,
pubmed-meshheading:11591618-Hand,
pubmed-meshheading:11591618-Humans,
pubmed-meshheading:11591618-Infusions, Intravenous,
pubmed-meshheading:11591618-Middle Aged,
pubmed-meshheading:11591618-Peptidyl-Dipeptidase A,
pubmed-meshheading:11591618-Reproducibility of Results,
pubmed-meshheading:11591618-Serine Endopeptidases,
pubmed-meshheading:11591618-Substrate Specificity,
pubmed-meshheading:11591618-Tetrazoles,
pubmed-meshheading:11591618-Vasoconstriction,
pubmed-meshheading:11591618-Veins
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
|
|
pubmed:affiliation |
CRI in Heart Failure, Department of Medicine and Therapeutics, University of Glasgow, Scotland, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
